期刊
CURRENT OPINION IN STRUCTURAL BIOLOGY
卷 41, 期 -, 页码 145-150出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.sbi.2016.07.020
关键词
-
资金
- National Institute of Health [GM083303, F32GM105205]
- Novartis Institutes for Biomedical Research
Drug combination is an appealing strategy for combating the heterogeneity of tumors and evolution of drug resistance. However, the rationale underlying combinatorial therapy is often not well established due to lack of understandings of the specific pathways responding to the drugs, and their temporal dynamics following each treatment. Here we present several emerging trends in harnessing properties of biological systems for the optimal design of drug combinations, including the type of drugs, specific concentration, sequence of addition and the temporal schedule of treatments. We highlight recent studies showing different approaches for efficient design of drug combinations including single-cell signaling dynamics, adaption and pathway crosstalk. Finally, we discuss novel and feasible approaches that can facilitate the optimal design of combinatorial therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据